Bronstein Ben 4
4 · Aldeyra Therapeutics, Inc. · Filed Jun 11, 2020
Insider Transaction Report
Form 4
Bronstein Ben
Director
Transactions
- Award
Stock Option (Right to Buy)
2020-06-09+26,503→ 26,503 totalExercise: $5.02Exp: 2030-06-08→ Common Stock (26,503 underlying) - Award
Stock Option (Right to Buy)
2020-06-09+2,311→ 2,311 totalExercise: $5.02Exp: 2030-06-08→ Common Stock (2,311 underlying) - Award
Stock Option (Right to Buy)
2020-06-09+1,541→ 1,541 totalExercise: $5.02Exp: 2030-06-08→ Common Stock (1,541 underlying)
Footnotes (3)
- [F1]Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date.
- [F2]Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Audit Committee of the Board of Directors of the Issuer through the applicable vesting date.
- [F3]Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Compensation Committee of the Board of Directors of the Issuer through the applicable vesting date.